A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors

NCT04478279 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

125

Enrollment

INDUSTRY

Sponsor class

Conditions

Glioblastoma
Melanoma Stage IV
Breast Cancer
Prostate Cancer
Glioblastoma Multiforme
GBM
Brain Cancer
Metastatic Breast Cancer
Metastatic Melanoma
Metastatic Prostate Cancer
Melanoma Recurrent
Prostate Cancer Metastatic
Recurrent Glioblastoma
Newly Diagnosed Glioblastoma

Interventions

DRUG: ST101
DRUG: Temozolomide
RADIATION: Radiation

Sponsor

Sapience Therapeutics